tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CCCC Stock Latest News

Brookline sees potential upside to outlook for C4 Therapeutics after Biogen news
The FlyBrookline sees potential upside to outlook for C4 Therapeutics after Biogen news
2d ago
BIIB
CCCC
C4 Therapeutics announces Biogen had its IND for BIIB142 accepted by FDA
PremiumThe Fly
C4 Therapeutics announces Biogen had its IND for BIIB142 accepted by FDA
3d ago
BIIB
CCCC
C4 Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
C4 Therapeutics initiated with a Buy at Guggenheim
3d ago
CCCC
C4 Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
C4 Therapeutics initiated with a Buy at Guggenheim
3d ago
CCCC
C4 Therapeutics to present data from Phase 1 trial of cemsidomide
PremiumThe Fly
C4 Therapeutics to present data from Phase 1 trial of cemsidomide
4d ago
CCCC
C4 Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsC4 Therapeutics Reports Q2 2025 Financial Results
30d ago
CCCC
C4 Therapeutics Completes Phase 1 Trial Enrollment
Premium
Company Announcements
C4 Therapeutics Completes Phase 1 Trial Enrollment
1M ago
8K
CCCC
C4 Therapeutics reports Q2 EPS (37c), consensus (38c)
Premium
The Fly
C4 Therapeutics reports Q2 EPS (37c), consensus (38c)
1M ago
CCCC
C4 Therapeutics sees cash runway into mid-2027
PremiumThe Fly
C4 Therapeutics sees cash runway into mid-2027
1M ago
CCCC
C4 Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
C4 Therapeutics Holds Annual Stockholders Meeting
3M ago
8K
CCCC
C4 Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
C4 Therapeutics Reports Q1 2025 Financial Results
4M ago
CCCC
C4 Therapeutics Updates on Cemsidomide Clinical Trial
PremiumCompany Announcements
C4 Therapeutics Updates on Cemsidomide Clinical Trial
4M ago
8K
CCCC
C4 Therapeutics reports Q1 EPS (37c), consensus (42c)
PremiumThe FlyC4 Therapeutics reports Q1 EPS (37c), consensus (42c)
4M ago
CCCC
C4 Therapeutics Board Member Bruce Downey Retires
Premium
Company Announcements
C4 Therapeutics Board Member Bruce Downey Retires
5M ago
8K
CCCC
C4 Therapeutics: Promising Clinical Developments and Strategic Plans Justify Buy Rating
Premium
Ratings
C4 Therapeutics: Promising Clinical Developments and Strategic Plans Justify Buy Rating
6M ago
CCCC
C4 Therapeutics Reports Strong 2024 Financial Performance and Clinical Progress
PremiumCompany Announcements
C4 Therapeutics Reports Strong 2024 Financial Performance and Clinical Progress
6M ago
CCCC
C4 Therapeutics reports Q4 EPS (49c), consensus (45c)
PremiumThe Fly
C4 Therapeutics reports Q4 EPS (49c), consensus (45c)
6M ago
CCCC
C4 Therapeutics sees cash runway into 2027
PremiumThe Fly
C4 Therapeutics sees cash runway into 2027
6M ago
CCCC
CCCC Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CCCC Upcoming Earnings Report: What to Expect?
7M ago
CCCC
C4 Therapeutics Outlines 2025 Milestones and Achievements
PremiumCompany AnnouncementsC4 Therapeutics Outlines 2025 Milestones and Achievements
8M ago
8K
CCCC
C4 Therapeutics announces anticipated 2025 milestones
Premium
The Fly
C4 Therapeutics announces anticipated 2025 milestones
8M ago
CCCC
C4 Therapeutics price target raised to $50 from $39 at Brookline
Premium
The Fly
C4 Therapeutics price target raised to $50 from $39 at Brookline
8M ago
CCCC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >